The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Extracapsular spread and adjuvant therapy in human papillomavirus‐related, p16‐positive oropharyngeal carcinoma
Open accessAbstract
BACKGROUND: Extracapsular spread (ECS) is commonly used to justify adjuvant chemotherapy in patients with head and neck cancer. The role of ECS as a prognosticator and adjuvant therapy determinant in surgically resected, human papillomavirus‐related oropharyngeal squamous cell carcinoma (OPSCC), however, has never been determined. METHODS: Of 210 oropharynx patients in a prospective transoral laser microsurgery database, 152 patients who had p16‐positive primary OPSCC and pathologically positive necks were eligible for the study. ECS was measured from routine reporting (ECS report) and by using a novel histologic grading system (ECS graded). Proportional hazards models and matched analyses were used to compare the impact of ECS and adjuvant therapy on disease‐free survival (DFS). Patients with and without graded ECS were matched for T‐stage, surgical margins, and adjuvant therapy. RESULTS: At a median follow‐up of 43 months, the presence of ECS was not associated with poorer DFS in multivariate analyses (ECS report: hazard ratio [HR], 3.42; 95% confidence interval [CI], 0.45‐25.88; P = .23; ECS graded: HR, 2.54; 95% CI, 0.88‐7.34; P = .09). T‐stage and high‐grade ECS, ie soft tissue metastasis (STM graded) were prognostic. Overall and in the presence of ECS or even STM, adjuvant CRT was not associated with better DFS over radiotherapy alone (HR, 0.25; 95% CI, 0.06‐1.13; P = .07). In addition, matched analyses demonstrated no significant reduction in DFS for the presence of ECS versus the absence of ECS or reduced DFS for the administration of adjuvant radiotherapy alone versus CRT in ECS‐positive patients. CONCLUSIONS: Routinely reported ECS was not prognostic in this study. Adjuvant CRT versus radiotherapy alone produced no improvement in DFS for ECS‐positive patients. The authors propose that de‐escalated adjuvant therapy should be considered for patients with p16‐positive OPSCC who undergo surgery and that routinely reported ECS should not be used to justify adjuvant chemotherapy. Cancer 2012;3519–3530. © 2011 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Cited by
Lydiatt, W. M., Patel, S. G., O'Sullivan, B., Brandwein, M. S., Ridge, J. A., Migliacci, J. C., Loomis, A. M., & Shah, J. P. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21389 · Cited by 1,625
Caudell, J. J., Gillison, M. L., Maghami, E., Spencer, S., Pfister, D. G., Adkins, D., Birkeland, A. C., Brizel, D. M., Busse, P. M., Cmelak, A. J., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0016 · Cited by 526
Koyfman, S. A., Ismaila, N., Crook, D., D'Cruz, A., Rodriguez, C. P., Sher, D. J., Silbermins, D., Sturgis, E. M., Tsue, T. T., Weiss, J., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01921 · Cited by 395
NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017
Adelstein, D., Gillison, M. L., Pfister, D. G., Spencer, S., Adkins, D., Brizel, D. M., Burtness, B., Busse, P. M., Caudell, J. J., Cmelak, A. J., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0101 · Cited by 371
Owadally, W., Hurt, C., Timmins, H., Parsons, E., Townsend, S., Patterson, J., Hutcheson, K., Powell, N., Beasley, M., Palaniappan, N., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1598-x · Cited by 277
Metadata
- Authors
- Sinha, P., Lewis, J. S., Piccirillo, J. F., Kallogjeri, D., & Haughey, B. H.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2011-11-15
- Volume
- 118
- Issue
- 14
- Pages
- 3519-3530
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1591118513
- Cited by
- 246
- References
- 1
- FWCI
- 8.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Extracapsular spread and adjuvant therapy in human papillomavirus‐related, p16‐positive oropharyngeal carcinoma. https://app.cochat.ai/papers/10.1002/cncr.26671
- The paper
- Sinha, P., Lewis, J. S., Piccirillo, J. F., Kallogjeri, D., & Haughey, B. H. (2012). Extracapsular spread and adjuvant therapy in human papillomavirus‐related, p16‐positive oropharyngeal carcinoma. Cancer. https://doi.org/10.1002/cncr.26671
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.